Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials

AIMS/INTRODUCTION: To assess efficacy and safety of insulin degludec/liraglutide (IDegLira) in Japanese participants with type 2 diabetes across different baseline characteristics. MATERIALS AND METHODS: Data from two randomized controlled trials were used: DUAL I Japan (n = 819 insulin‐naïve partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Komatsu, Mitsuhisa, Watada, Hirotaka, Kaneko, Shizuka, Ross Agner, Bue F, Nishida, Tomoyuki, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409843/
https://www.ncbi.nlm.nih.gov/pubmed/33595901
http://dx.doi.org/10.1111/jdi.13525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409843/
https://www.ncbi.nlm.nih.gov/pubmed/33595901
http://dx.doi.org/10.1111/jdi.13525

Ejemplares similares